Arla Foods Ingredients Lacprodan MFGM-10

Milk fat globule membrane (MFGM) has been approved for use in infant formula products in Australia, with Arla Foods Ingredients granted exclusive commercialisation rights.

The decision means that Lacprodan MFGM-10 will be Arla Foods Ingredients’ first early life nutrition product to be approved by Australian authorities. It is also claimed to be the only MFGM ingredient approved for use in products for infants in the country for at least 15 months.

On 30 April 2025, Food Standards Australia New Zealand (FSANZ) approved the use of MFGM as a nutritive substance in infant formula products. Following formal acceptance by the Australia and New Zealand Food Ministers’ Meeting, the approval is now effective.

It applies across Australia, where Lacprodan MFGM-10 can be labelled as ‘Milk fat globule membrane-enriched whey protein concentrate’, but not New Zealand, which recently opted out of the Australia–New Zealand joint infant formula products standard. Earlier this year, it was confirmed that Lacprodan MFGM-10 is not considered a novel food in the EU, allowing its use in products for infants, as well as adults.